This week, health officials in the United Kingdom shared how an artificial intelligence-enabled platform has drastically improved stroke outcomes in the region.

NIH is hopeful the research will enable doctors to detect signs of stroke damage earlier, opening the door for them to initiate treatments in a timelier manner.

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

Mastering the art of effective prompts has become a coveted skill in the fast-growing field of AI. 

If left untreated, SDH expansion puts added pressure on the brain, which can lead to damage, impaired neurological function and even death. 

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage. 

Researchers say their findings suggest that medications that increase prefrontal dopamine "are an important lead to pursue.” 

The method utilizes findings from PET/MR imaging to differentiate between changes in tissue owed to treatment versus tumor progression.